Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease

Pediatric Infectious Disease Journal

Volumn 26, Issue 7, 2007, Pages 655-656

  Davis, Carla M ^a   Noroski, Lenora M ^a   Dishop, Megan K ^a   Sutton, Deanna A ^b   Braverman, Richard M ^a   Paul, Mary E ^a   Rosenblatt, Howard M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Chronic granulomatous disease; Fungal infection; Inonotus tropicalis; Osteomyelitis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; VORICONAZOLE;

ABSCESS; ADULT; ARTICLE; BASIDIOMYCETES; BIOPSY; BONE MARROW BIOPSY; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INONOTUS TROPICALIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SACRUM; X CHROMOSOME LINKAGE;

ADULT; ANTIFUNGAL AGENTS; BASIDIOMYCOTA; GRANULOMATOUS DISEASE, CHRONIC; HMGB1 PROTEIN; HUMANS; MALE; MYCOSES; OSTEOMYELITIS; PEPTIDES, CYCLIC; PYRIMIDINES; SACRUM; TRIAZOLES;

EID: 34347325201     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e3180616cd0     Document Type: Article

References (16)

1. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000;79:155- 69.
2. Sponseller PD, Malech HL, McCarthy EF Jr, et al. Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg Am. 1991;73:37-51.
3. Kline MW, Bocobo FC, Paul ME, et al. Successful medical management of aspergillus osteomyelitis of the spine in an 11 year old boy with chronic granulomatous disease. Pediatrics. 1994;93:830-835.
4. Sutton DA, Thompson EH, Rinaldi MG, et al. Identification and First Report of Inonotus(=Phellinus) tropicalis as an etiologic agent in a patient with chronic granulomatous disease. J Clin Microbiol. 2005;43:982-987.
5. Liu Z, Hou T, Shen Q, et al. Osteomyelitis of sacral spine caused by Aspergillus versicolor with neurologic deficits. Chin Med J. 1995;108:472-475.
6. Roilides E, Sigler L, Bibashi E, et al. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol. 1999;37:18-25.
7. Gonzalez GM, Sutton DA, Thompson E, et al. In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi. Antimicrob Agents Chemother. 2001;45:633-635.
8. Song YS, Kim SH, Sa JH, et al. Anti-angiogenic, antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus. J Ethnopharmacol. 2003;88:113-116.
9. Han SB, Lee CW, Jeon YJ, et al. The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology. 1999;41:157-164.
10. Kim HM, Han SB, Oh GT, et al. Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus. Int J Immunopharmacol. 1996;18:295-303.
11. Kwon SI, Anderson AJ. Catalase activities of Phanerochaete chrysosporium are not coordinately produced with ligninolytic metabolism: catalases from a white-rot fungus. Curr Microbiol. 2001;42:8-11.
12. Ghannoum MA. Is antifungal susceptibility testing useful in guiding fluconazole therapy? Clin Infect Dis. 1996;22(suppl 2):S161-S165.
13. Segal B, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine. 2000;79:170 -200.
14. Watanabe C, Yajima S, Taguchi T, et al. Successful unrelated bone marrow transplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant. 2001;28:83-87.
15. Horwitz ME, Barrett AJ, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med. 2001;344:881-888.
16. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002;100:4344-4350.